Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3197
Selected: 0
NCT IDTitle
NCT06431347Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health
NCT01436084SB1518 for Patients With Myelodysplastic Syndrome (MDS)
NCT00490503Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
NCT01619761NK Cells in Cord Blood Transplantation
NCT01663870Technology and Navigation to Improve Survivorship Care
NCT00800566Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
NCT00968253RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
NCT05715216EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
NCT04592250Financial Toxicity in Cancer Patients
NCT06434350Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
NCT02385110Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
NCT02697799A Randomized Trial of Recruitment Strategies for Research Participation
NCT02481349Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their Partners
NCT04729725SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL
NCT04751396Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
NCT06785441Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
NCT06878131Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
NCT00242502Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery
NCT06959511Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
NCT05488444A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care
NCT06840288Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry
NCT00901927Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
NCT02697227Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
NCT05049837PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
NCT04185337Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes
NCT03573375Barriers Affecting Physical Activity
NCT05873192Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
NCT07101432Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
NCT01709292Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
NCT05035836A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
NCT01432132Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer
NCT03452332Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
NCT05041153Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
NCT04629677Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
NCT02464657Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
NCT00473122Delayed-Immediate Breast Reconstruction
NCT03674229Patients Navigators in Facilitating Weight Management in Obese Participants
NCT00634257Spirituality/Religiosity in Patients and Caregivers
NCT05347212Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
NCT02494700Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma
NCT02659241Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT01311856Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors
NCT05051345Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast Texas
NCT04986670NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer
NCT06373354Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
NCT02095054Regorafenib and Cetuximab in Patients With Advanced Malignancy
NCT05094466Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority Families
NCT00614653Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
NCT03599765Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
NCT00675441Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)